Anaphylactoid reactions to radiocontrast agents: Prevention and treatment in the cardiac catheterization laboratory

Journal of Invasive Cardiology

Volumn 21, Issue 10, 2009, Pages 548-551

  Nayak, Keshav R ^a   White, Andrew A ^b   Cavendish, Jeffrey J ^c   Barker, Colin M ^a   Kandzari, David E ^a  

^a Division of Cardiovascular Diseases

^b SCRIPPS CLINIC   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CLOPIDOGREL; CONTRAST MEDIUM; DIPHENHYDRAMINE; PENICILLIN G;

ADVERSE DRUG REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; DISEASE SEVERITY; FEVER; HEART CATHETERIZATION; HUMAN; HYPERSENSITIVITY; LABORATORY TEST; MACULOPAPULAR RASH; PATHOGENESIS; PRACTICE GUIDELINE; PRURITUS; REVIEW; RISK FACTOR; URTICARIA;

ANAPHYLAXIS; CONTRAST MEDIA; EPINEPHRINE; HEART CATHETERIZATION; HISTAMINE ANTAGONISTS; HUMANS; STEROIDS;

EID: 72649100847     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Brooks B. Intra-arterial injection of sodium iodide. JAMA 1924;82:1016-1019.
2. Cochran ST. Anaphylactoid reactions to radiocontrast media. Curr Allergy Asthma Rep 2005;5:28-31.
3. Goss JE, Chambers CE, Heupler FA Jr. Systemic anaphylactoid reactions to iodinated contrast media during cardiac catheterization procedures: Guidelines for prevention, diagnosis, and treatment. Laboratory Performance Standards Committee of the Society for Cardiac Angiography and Interventions. Cathet Cardiovasc Diagn 1995;34:99-104.
4. American Heart Association. Heart disease and stroke statistics - 2008 Update. Circulation 2008;117:e25-e146.
5. Canter LM. Anaphylactoid reactions to radiocontrast media. Allergy Asthma Proc 2005;26:199-203.
6. Caro JJ, Trinidade E, McGregor M. The risk of death and of severe nonfatal reactions with high- vs. low-osmolality contrast media: A meta-analysis. AJR Am J Roentgenol 1990,156:825-832.
7. Hagan JB. Anaphylactoid and adverse reaction to radiocontrast agents. Immunol Allergy Clin N Am 2004;24:507-519.
8. Bush WH, Swanson DP. Acute reactions to intravascular contrast media: Types, risk factors, recognition, and specific treatment. Am J Roent 1991;157:1153-1161.
9. Morcos SK, Thomsen HS. Adverse reactions to iodinated contrast media. Eur Radiol 2001;11:1267-1275.
10. Lang DM, Alpern MB, Visintainer PF, Smith ST. Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers with asthma. Ann Intern Med 1991;115:270-276.
11. Lang DM, Alpern MB, Visintainer PF, Smith ST. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med 1993;153:2033-2040.
12. Choyke PL, Miller DL, Lotze MT, et al. Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 1992;183:111-114.
13. Lang DM, Alpern MB, Visintainer PF, Smith ST. Gender risk for anaphylactoid reaction to radiographic contrast media. J Allergy Clin Immunol 1995;95:813-817.
14. Chagnac Y, Hadani M Goldhammer Y. Myasthenic crises after intravenous administration of iodinated contrast agent. Neurology 1985;35:1219-1220.
15. Beaty, A, Lieberman, P, Slavin, R. Seafood allergy and radiocontrast media: Are physicians propagating a myth? Am J Med 2008;121:158.e1-e158.
16. Laroche D, Aimone-Gastin I, Dubois F, et al. Mechanisms of severe immediate reactions to iodinated contrast material. Radiology 1998;209:183-190. (Pubitemid 28464665)
17. Assem KSE, Bray K, Dawson P. The release of histamine from human basophils by radiological contrast agents. Br J Radiol 1983;56:647-652.
18. Peachell P, Morcos SK. Effect of radiographic contrast media on histamine release from human mast cells and basophils. Br J Radiol 1998;71:24-30.
19. Tricka J, Schmidt C, Seitz C. et al. Anaphylaxis to iodinated contrast material: Nonallergic hypersensitivity or IgE-mediated allergy? Am J Radiol 2008;190:666-670.
20. Yasuda R, Munechika H. Delayed adverse reactions to nonionic monomeric contrast- enhanced media. Invest Radiol 1998;33:1-5.
21. Kanny G, Pichler W, Morisset M, et al. T cell-mediated reactions to iodinated contrast media: Evaluation by skin and lymphocyte activation tests. J Allergy Clin Immunol 2005;115:179-185.
22. Lasser EC, Berry CC, Talner LB, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med 1987;317:845-849.
23. American College of Radiology Committee on Drugs and Contrast Media. ACR Manual on Contrast Media, 5th ed. Reston, VA: American College of Radiology, 2004, pp. 5-77.
24. Bohm I, Speck U, Schild, H. A possible role for cysteinyl-leukotrienes in non-ionic contrast media induced adverse reactions. Eur Radiol 2005;55:431-436.
25. Williams AN, Kelso JM. Radiocontrast-induced anaphylaxis despite pretreatment and use of iso-osmolar contrast. Ann Allergy Asthma Immunol 2007;99:467-468.
26. Sampson HA, Munoz-Furlong A, Bock SA, et al. Symposium on the definition and management of anaphylaxis: Summary report. J Allergy Clin Immunol 2005;115:584-591.
27. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000;30:1144-1150.
28. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opinion in Allergy and Clinical immunology 2005;5:359-364.
29. Mueller UR. Cardiovascular disease and anaphlaxis. Curr Opin Allergy Clin Immunol 2007;7:337-341.
30. Mink SN, Simons FE, Simons KJ, et al. Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clin Exp Allergy 2004;34:1776-1783.
31. Lieberman P. Use of epinephrine in the treatment of anaphylaxis Current Opinion in Allergy and Clinical Immunology 2003;3:313-318.